scholarly journals A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study

2019 ◽  
Vol 155 (3) ◽  
pp. 393-399 ◽  
Author(s):  
Roisin E. O’Cearbhaill ◽  
Wei Deng ◽  
Lee-may Chen ◽  
Joseph A. Lucci ◽  
Kian Behbakht ◽  
...  
2007 ◽  
Vol 177 (4S) ◽  
pp. 35-35
Author(s):  
Gianluca Giannarini ◽  
Andrea Mogorovich ◽  
Girolamo Morelli ◽  
Maurizio De Maria ◽  
Francesca Manassero ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document